MJ Powers & Co publishes monthly newsletters about the efficacy and safety of drugs and therapeutics. The Alerts contain summaries, from a wide variety of journals, that can help you solve a problem, warn you about safety, or reassure you about efficacy. Not only will you receive the latest research findings, but also useful tools to help you judge research quality, evaluate study independence, and guide you with statistics. 

The Alerts Newsletters are timely and thorough, and you can be assured of objectivity because MJ Powers & Co is independent. There is no sponsorship associated with any of our newsletters, and we accept no advertising. In addition, as a subscriber you will be eligible to enroll in our CME program, which your colleagues consistently rate as "excellent" and "practice changing". 
  • CBT for Relapse Prevention in Depression
  • Adjunctive Raloxifene in Schizophrenia
  • Impulsive Aggression: Treatment Algorithm
  • Statins Plus Vitamin D for Migraine Prevention
Copyright © 2015 M.J. Powers & Company Publishers. All rights reserved
HomeProductsContinuing EducationSubscriber Services

Contact UsPsychiatry Drug AlertsPsychiatry Alerts NOSChild & Adol Psy AlertsPrimaryCare Drug Alerts

MJ Powers & Co Publishers is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. 

MJ Powers & Co Publishers has been approved by the American Board of Psychiatry and Neurology (ABPN) to provide CME and Self-Assessment credit for use toward maintenance of certification.

ABPN MOC Self-Assessment CME NOW Available . . . Click here for details


Click on a newsletter to view a sample.           


In Progress for Upcoming Issues